abstract |
This invention provides methods of inhibiting the export of a leaderlessnprotein from a cell by contacting the cell with a cardiac glycoside or aglycone derivative.nLeaderless proteins include FGF-1, FGF-2, IL-1α, IL-1β and factor XIIIa. These methodsnare useful in treatment of conditions, including tumors and diabetes. |